Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-2024-08-06· OpenAIAi2 WildChat-4.8M (AI2)

"Laser technology is a true game-changer. There are applications we haven’t yet…

  1. User

    "Laser technology is a true game-changer. There are applications we haven’t yet conceived of" Brigadier General Ran Kochav, former commander of the Israeli Air Missile Defense Forces, believes that the introduction of Iron Beam, a laser interception system, heralds a profound change in warfare and believes that the day is not far off when fighter jets will be able to destroy ground targets from the air with total silence and precision. Yuval Azulay 10:02, 11.11.24 TAGS: Missile Defense Iron Beam Iron Dome Israeli Air Force

    Brigadier General (res.) Ran Kochav, a former commander of the Israeli Air Missile Defense Forces, refuses to ride the wave of euphoria dominating the public discourse surrounding the laser-based Iron Beam defense system, which will be delivered to the IDF next year and enter operational use. Last week, the Ministry of Defense signed a contract with Rafael and Elbit Systems for an order valued at approximately NIS 2 billion (533million)topurchasetheworld’sfirstsystemofitskindforinterceptingshort−rangerocketsatnearlyzerocost.It’simportanttonotethatthesystemistheresultofatechnologicalbreakthroughfollowingdecadesofresearchanddevelopment,positioningIsraelwhereevensuperpowershavestruggled.However,Kochav,whoretiredlastsummerfromtheIDFafter35years,mostofwhichhespentintheAirDefenseCorps,expressesreservationsaboutthepublic’sexpectations."Ourproblemisthatweinflateexpectations.Everysuccesshereisseenasatriumphandeveryminorfailureisconsideredadebacle,"hesaysinaninterviewwithCalcalist.HereAre39oftheCoolestGiftsforThis2024TrendingGiftsCo−FounderofGoogleBrain,AndrewNg,Recommends:5BooksForTurningYourLifeAroundBlinkist:AndrewNg′sReadingList30photosthatreallymakeyouthinkHighTallybyTaboolaSponsoredLinksכוכב."צריךלקחתבחשבוןשכמושאנחנונשתמשבלייזרשיגןעלארובותתחנתהכוחבחדרה,יהיהלייזרשיגןעלמתקניאנרגיהבטהרן"BrigadierGeneral(res.)RanKochav.(Credit:YonatanBloom)"Icomefromtheairdefenseworldandamveryfamiliarwiththeparadoxofsuccess.Take,forinstance,thedronethreat.Weintercept80Monday.comhits533 million) to purchase the world’s first system of its kind for intercepting short-range rockets at nearly zero cost. It’s important to note that the system is the result of a technological breakthrough following decades of research and development, positioning Israel where even superpowers have struggled. However, Kochav, who retired last summer from the IDF after 35 years, most of which he spent in the Air Defense Corps, expresses reservations about the public’s expectations. "Our problem is that we inflate expectations. Every success here is seen as a triumph and every minor failure is considered a debacle," he says in an interview with Calcalist. Here Are 39 of the Coolest Gifts for This 2024 Trending Gifts Co-Founder of Google Brain, Andrew Ng, Recommends: 5 Books For Turning Your Life Around Blinkist: Andrew Ng's Reading List 30 photos that really make you think High Tally by TaboolaSponsored Links כוכב. "צריך לקחת בחשבון שכמו שאנחנו נשתמש בלייזר שיגן על ארובות תחנת הכוח בחדרה, יהיה לייזר שיגן על מתקני אנרגיה בטהרן" Brigadier General (res.) Ran Kochav. (Credit: Yonatan Bloom) "I come from the air defense world and am very familiar with the paradox of success. Take, for instance, the drone threat. We intercept 80% of them, but if we miss one or two, people immediately claim it was a failure. But that’s not the case. A true failure was October 7 - that’s the ultimate debacle. We have a 90% success rate in intercepting rockets and missiles that we want to shoot down. Still, for those who are hit by a drone, missile, or rocket that wasn’t intercepted, there’s no success, because they were harmed. Nothing is perfect; there’s no such thing as an airtight defense." Monday.com hits 1 billion in ARR - and Israel is developing its own Waze? | CTech 129K 1 Play Video logo Even with a laser? "Correct. The laser will solve many problems for us, but not all of them. Technologically, we’re getting closer to a solution, but there’s a safety issue: the laser beam is not selective, and it burns anything in its path - say, an aircraft that you don’t want to hit. Beyond that, it has efficiency limitations in certain weather conditions - haze and clouds reduce its effectiveness. The beam also doesn’t follow a ballistic trajectory like a missile does, meaning it requires line of sight to the target." “I have no doubt that Donald Trump is anti-Semitic” | CTech CTech From Intel to Meta: How high-tech giants are rethinking employee perks | CTech CTech Ad
    Related articles: Laser-powered defense: How Iron Beam aims to transform Israel’s air defense capabilities Israel’s Iron Beam laser defense system set for 2025 operational launch following $500M expansion Israel’s laser defense system nears operational status amid intensified rocket barrages

    Still, the cost of interceptions will be greatly reduced. Currently, an Iron Dome missile costs around $50,000 to intercept a rocket that costs only a few hundred dollars. "There's no doubt that this will be a fantastic defense system, a marvel of technological innovation that will reduce interception costs by several degrees. It will serve as an excellent complement to Iron Dome, but it’s advisable to set realistic expectations with the public - it won’t solve all our problems. Let’s tone it down." A new kind of warfare The recent breakthrough by Israeli defense industries is driven by a persistent need, similar to what led to the development of Arrow by Israel Aerospace Industries, and Rafael’s Iron Dome, David’s Sling and Trophy which protects tanks and armored vehicles from anti-tank missiles and RPGs. While, at least in its initial deployment, Iron Beam will have limited capabilities in range and operations amid challenging weather conditions, it establishes Israel as a pioneer in high-powered laser weaponry. Turning the Iron Beam system operational may also carry historic significance, marking the beginning of a shift to a new type of weapon that has so far existed only in science fiction. If this vision is realized, armies will no longer need massive missiles carrying hundreds of kilograms of explosives that soar beyond the atmosphere to strike distant targets, nor metallic projectiles fired at supersonic speeds with thunderous noise. Even target destruction would no longer create an ear-splitting explosion. This won’t happen in the next year or two, but laser technology is here, and it will form the basis for additional weaponry developed and manufactured in the coming years. Defense industry engineers are already likely envisioning laser-based offensive systems that will reshape future battlefields, even if the development plans remain classified. In the near term, the primary efforts will focus on defense to neutralize a wide array of airborne threats: from hostile fighter jets to missiles, rockets, and even drones, attacking UAVs, and anti-tank missiles in mid-flight. Rafael is still working on the ground-based version of the Iron Beam, preparing it for integration into Iron Dome batteries. כוכב עם רמטכ"ל צבא יפן קוז׳י ימזאקי בביקור בסוללת כיפת ברזל, 2019 . "שמתי את תחום המעופפים בעדיפות שנייה לטובת טיפול בטילים" Kochav with the Chief of Staff of the Japanese Army Koji Yamazaki visiting the Iron Dome battery in 2019. (Credit: IDF Spokesperson's Unit) Meanwhile, Elbit is developing an airborne version, potentially replacing the missiles currently used to down hostile aircrafts, missiles, and UAVs. In this case, the limitations of a ground-based system become advantages, as firing the laser above the cloud layer enables the system to be effective at a longer range. For this vision to come to fruition, Elbit’s engineers must overcome technological challenges such as shrinking the laser’s guidance system and power sources to enable installation on various aircraft, and stabilizing the light beam as it’s directed from one maneuvering aircraft to another. In recent days, defense industry leaders have hinted that the hardest parts of these challenges are already behind them. Perhaps because of this, when asked about the future capabilities emerging in the secret labs of Israeli weapons companies, Kochav sheds the restraint he showed regarding Iron Beam and eagerly explains how this innovative system could integrate into the IDF’s air defense array. “Imagine a scenario where an enemy from the north wants to attack Hadera’s power station. Ideally, we’d aim to neutralize this threat before it even takes off, eliminating its launch capability. If the missile or UAV is launched anyway, we would intercept it before it crosses into Israeli territory using a forward-facing laser, thereby avoiding 4 a.m. alarms. Just for that, it’s worth it.” And if the threat has already crossed the border and is advancing towards its target? “In that case, we’d have a double defense. On its way to the target, the threat would encounter an interceptor from a defense battery like Iron Dome, and if it managed to evade that, it would face another laser interceptor near its target.” In a reality where air defense systems sometimes struggle to track hostile aircraft breaching Israeli airspace, this vision seems almost fanciful. Yet, technologists are already thinking of the next phase: using laser technology as an offensive weapon. “Currently, we hope that this technology can significantly reduce the missile, aircraft, and rocket threat, but in the future, we envision additional applications we haven’t yet conceived of. For instance, if a laser beam can be directed from the ground to a target in the air, or from one target in the air to another, why shouldn’t we fire it from the air to the ground as well? In fact, we already do this when we designate a target with a laser for a laser-guided missile. So, why shouldn’t the laser spot itself be the weapon rather than the missile? Such adjustments turn this into a true game-changer. The technology is already proven. Now, efforts are underway to apply it across different weapons systems.” Using such systems would also allow for significant cost savings in an era in which demand for weapons is only increasing. “Absolutely, and that’s the third hopeful aspect of laser-based weapons. Kinetic defense as we know it today is costly and complex. If laser weaponry eventually replaces or complements it, the cost per interception will be lower than the cost of the incoming rocket, reversing the equation. Currently, defensive weaponry costs more than most offensive weapons it counters.” Would this also redefine economics of arms? “Completely. There will be geopolitical implications because we won’t need extensive foreign weapons support. Also, if we encounter a simultaneous attack on Hadera and Caesarea, we won’t need to quickly decide which target is more important to defend, as we won’t face the limitations imposed by finite interceptor inventories.” מערכת מגן אור מערכת לייזר ל יירוט רקטות Iron Beam. (Photo: IDF Spokesman) A fast-changing future Future warfare, in which laser weapons become standard, will be silent and precise. “This kind of war will be very quiet and conducted at extremely high speeds,” says Kochav. “The laser beam is invisible to the naked eye, there won’t be a sound of explosions because the beam launch is silent, and even the impact on the target will look different. In this scenario, there’s no explosive involved but a concentration of energy in a beam the size of a 10-shekel coin or even smaller. There will be a target and then it will simply disappear,” he explains. And when the beam intercepts targets in the air, will there be no explosions or smoke? “Exactly. The laser beam will hit the target at the speed of light, in fractions of a second. It will heat the target’s exterior, melt parts of it, and the target will just fall to the ground as debris. In future operational applications, it will be possible to control the beam’s power and focus more energy for a large target and less for a smaller one.” According to Rafael, Iron Beam’s main contractor, the laser’s power, currently planned for 100 kilowatts, may become stronger, more stable, and deadlier in the future. To meet these objectives and create a product portfolio based on lasers for global military markets, Rafael is partnering with U.S. defense giant Lockheed Martin. This collaboration signifies American recognition that Israel leads in this field and Israel could soon become the first country to implement a reliable and efficient operational military laser system. However, Israel is not the only country advancing in laser weaponry. Earlier this year, the British Ministry of Defense announced that it had conducted a series of tests in Scotland, firing a laser at an airborne target for the first time. Recently, reports have emerged of robust Chinese activity in the field, and there are indications that Iran has acquired a Chinese-made laser system providing some defense against drones and UAVs. While its capabilities are far behind those of the Iron Beam in terms of range and power, Iran’s motivation to develop similar capabilities to Israel’s should not be underestimated. In other words, although Israel currently leads the competition, there’s no guarantee that other determined nations won’t eventually acquire similar technology. The drone threat - a major concern for the Israeli Air Force - is an example of how advanced technologies can quickly filter down to terror organizations. Just a decade or two ago, UAVs were the domain of technologically advanced countries like Israel and the U.S., but in recent years, new players like China, Iran, and Turkey have joined, making drones widely available, affordable, and sought-after weapons. Iranian drones have become a significant part of Russia’s offensive arsenal in Ukraine and are supplied generously to proxy organizations Hezbollah, the Houthis, and Iraqi militias which form the “ring of fire” around Israel. We can assume that our current technological superiority will be short-lived and soon we’ll have to develop defense systems against laser weapons as well. “Just as we planned today’s air defense system 20 years ago - which in 2024 is performing very well - it’s wise for knowledgeable experts to start thinking now about the air defense Israel will need in 2048, when laser weapons will be a significant part of the battlefield. We should prepare for our enemies to possess such weapons too. Just as we’ll use lasers to protect the power station stacks in Hadera, lasers will protect energy facilities in Tehran. Alternatively, we must prepare for a scenario where a mysterious laser beam could take down a Boeing with hundreds of passengers as it lands at a British, American, or Israeli airport.” Identifying the target Until this futuristic vision becomes a reality, the most significant challenge the Air Force faces regarding drone attacks is the difficulty in detecting them before they hit their target. For instance, this past July, a drone launched from Yemen managed to hit a building near the U.S. Embassy in Tel Aviv and killed a civilian without being detected. Last month, a drone launched from Lebanon crashed onto the roof of the Golani Brigade's training base dining hall near Binyamina, killing four soldiers and injuring dozens. Another recent incident involved a drone launched from the north, which exploded on the window of the Prime Minister’s bedroom in Caesarea. In all these cases, no warning sirens were triggered. From 2018-2021, you commanded the Air Defense Command when drones were already a concern. Why have such incidents happened? "I take responsibility for this and I’m not blaming anyone else - not the Air Force commander or my successor in air defense command. I prioritized airborne threats second to the critical goal of responding effectively to missile and rocket threats. In the case of drones, I knew I’d get assistance from the Air Force’s primary mission: protecting Israeli airspace through fighter jets, attack helicopters, aerial control units, and electronic warfare tools. As the air defense commander, I understood I was solely responsible for missiles and rockets. If I didn’t focus on them, there would be a bloodbath due to missile and rocket fire targeting the home front. Budget limitations were tight, but despite our lesser capabilities in intercepting drones, I don’t see this as a failure. These decisions were sound." Today, with a better understanding of the drone threat, would you decide differently? "I don’t think so. Sure, more radars could have been deployed to improve detection, and more resources could have been allocated to this threat. But a limited budget doesn’t absolve me of responsibility, nor am I avoiding it. I’m responsible for the bad outcomes and for the good ones." Were missile interceptions prioritized over drones because surface-to-surface missiles are deadlier than drones? "I’m not minimizing the casualties from drone attacks. But the priority was to address existential threats like nuclear capabilities. And, even setting nuclear threats aside, a missile with a half-ton explosive warhead hitting this building we’re sitting in would create a crater. If a drone with five kilograms of explosives hit, you’d be injured, maybe even killed." I was recently up north and saw an Israeli F-16 pursuing a drone launched from Lebanon at a very low altitude, trying to intercept it. It was heartbreaking. "Forget heartbreaking; it’s dangerous. The fact that we haven’t had a fighter crash into the ground while pursuing such a drone is only thanks to our pilots' professionalism. A momentary lapse and you’re in the ground. A fighter jet chasing something that looks like a fly from the cockpit poses an enormous risk of disorientation." Hezbollah has adopted a challenging tactic by launching drones amid rocket salvos, attempting to overwhelm defense systems with targets. How do you counter this? "This is a significant challenge and there are defensive zones with set priorities, determining what’s most critical." Who decides? "Some decisions are made according to Air Force Command policy, while others are determined by the General Staff or political leadership." Are there dilemmas? "Certainly. If a target approaches the Ramat David base and another one nears Yokneam, which do you intercept first and which do you protect first? If you choose Ramat David, people might be killed in Yokneam, and if you prioritize Yokneam, the base could be hit. In these scenarios, priorities are established, but naturally, I can’t elaborate." The poison machine effect In the last two years of his service, Kochav was the head of the IDF Spokesperson's Unit. In March 2023, Brigadier General Daniel Hagari replaced him in the role. Last July, while he was supposed to be on study leave as a research fellow at RUSI in London, he unexpectedly announced his retirement. Today, he heads a company called Four Stars which provides consulting and business development services in air defense for European countries. “My relationship with Chief of Staff Herzi Halevi is good,” he says. “I informed him that I was going on retirement leave but I still keep a pair of shoes in my car and am ready to report for duty if needed. I closed the door behind me but didn’t slam it shut. I’m an IDF soldier for life, yet I have criticisms which I’ve shared with those who need to hear them.” It’s been 13 months since the failure of October 7, and Halevi is still in his position. Wouldn’t it be better for him to step down? “He should complete his term. I believe he knows this and just needs to find the right timing.” הרמטכ"ל רב אלוף הרצי הלוי מלחמת חרבות ברזל 2.8.24 IDF Chief of Staff Herzi Halevi. (Credit: IDF Spokesperson's Unit) What is the right timing? “I think he should have already announced it and not just him. Other General Staff members should have resigned like the Head of Military Intelligence and the Commander of the Gaza Division did. This isn’t an unreasonable expectation.” Investigations haven’t even been conducted yet. This undermines what public trust remains in the army. “Other than the Be’eri investigation (regarding tank fire on a home in Kibbutz Be'eri), we haven’t seen a single serious investigation. The IDF Spokesperson said everything would be done with transparency but, it’s fair to ask, when? Public trust in the IDF was severely damaged on October 7 and it was already in crisis during the judicial overhaul when the debate revolved around whether these moves impacted military preparedness. The army remained silent on the issue but in situations like these there’s no vacuum. That void is filled by actors with special interests, usually politicians.” What happened to us on that horrible morning? “I have no idea. I personally feel responsibility, shame, and guilt, even though I left the army seven months before the attack, and although the three units I commanded in recent years (the IDF Spokesperson’s Unit, the Air Defense, and the Military Police) performed excellently. I feel ashamed in front of my children, three of whom are now serving in the army and are involved in the war effort. If they’re the generation of victory, then we’re the generation of failure and I feel like a part of that.” In this war, Hagari has become the de facto national spokesperson. Do you think that’s appropriate? “My view on this is different from most past IDF spokespersons.” What’s your opinion? “That he shouldn’t be the national spokesperson. It doesn’t serve the IDF or the Spokesperson’s Unit, because no matter what the IDF Spokesperson says, it never comes across well.” If Hagari doesn’t speak, no one will. The prime minister only steps in front of the cameras when there are successes and achievements. “We need to establish a law stating that it is the state that should communicate the activities of government ministries. It’s not the role of a uniformed officer to handle issues like civilian evacuations, nor is it the Northern Command general’s job to inform people whether they can return to their homes. When a uniformed officer addresses such questions, it’s not beneficial internationally, as people abroad see him as they would the military spokesperson for the Houthis.” Like Hagari in recent months, Kochav also became a target of the right-wing’s poison machine during his service. At the end of 2022, a security guard was assigned to him for about two months, and his home in Caesarea was surrounded by cameras following threats on your life. “All I said on air was that burning villages isn’t legal or ethical, it diverts the IDF’s focus, and - in my view - it’s not Jewish either. The entire poison machine was unleashed against me,” he says now. Did you feel threatened? “I didn’t think someone genuinely wanted to kill me, but when you get calls in the middle of the night which immediately hang up, and you’re personally attacked online, it’s unpleasant. Afterward, the same thing happened to Central Command Chief Yehuda Fox, and my security guard was transferred to him, and later to the Chief Military Advocate General, Major General Yifat Tomer-Yerushalmi. It’s unbearable, especially since no one knows my political views, and many of those making threats haven’t served in the army themselves. And if laws are passed to protect draft-dodging and break-ins at IDF bases, where are we headed?” Where? “Sde Teiman scares me more than Yemen. We’ll know how to handle the Iranians, but we won’t know how to handle a state that devours its own army. We’re sawing off the root that holds up the tree, and it’s dangerous. You asked why I retired last July and the answer is partly because it became unbearable to be a public servant.” لطفا این خبررا به صورت یک گزارش خبری کوتاه به فارسی بنویس

  2. Assistant

    بریگادیر جنرال ران کوچاو، فرمانده سابق نیروهای دفاع موشکی هوایی اسرائیل، به تازگی در مصاحبه‌ای با "کالکالیست" درباره پیشرفت‌های سیستم دفاعی لیزری اسرائیل به نام "آیرون بیم" صحبت کرده است. این سیستم که نقطهٔ عطفی در فناوری دفاعی محسوب می‌شود، قرار است به زودی به ارتش اسرائیل تحویل داده شود و وارد عملیات گردد. هفته گذشته، وزارت دفاع اسرائیل قراردادی به ارزش تقریبی 2 میلیارد شِکِل (معادل 533 میلیون دلار) با شرکت‌های "رافائل" و "البیت سیستمز" برای خرید این سیستم امضا کرد.

    کوچاو تأکید می‌کند که انتظار عمومی از این سیستم نباید خیلی زیاد باشد. او معتقد است که موفقیت و شکست در دفاع هوایی نباید به سادگی قضاوت شود. سیستم "آیرون بیم" می‌تواند بسیاری از مشکلات را حل کند، اما درباره‌ی ایمنی و کارایی آن در شرایط خاص آب و هوایی محدودیت‌هایی وجود دارد.

    این پیشرفت تکنولوژیک ممکن است آغازگر تغییرات بزرگی در میدان جنگ باشد و به کاهش چشمگیر هزینه‌های رهگیری موشک‌ها و تهدیدات هوایی کمک کند. اگرچه انتظار می‌رود این تکنولوژی به سرعت در میدان نبرد آینده کاربرد پیدا کند، هنوز چالش‌هایی برای توسعه سیستم‌های تهاجمی مبتنی بر لیزر وجود دارد.

    اسرائیل در حال حاضر پیشگام در فناوری سلاح‌های لیزری است و با کشورهایی نظیر آمریکا برای توسعه سیستم‌های نظامی پیشرفته همکاری می‌کند. این در حالی است که کشورهایی مانند چین و ایران نیز در حال توسعه سیستم‌های مشابه هستند که می‌تواند تهدیدی برای اسرائیل محسوب شود. کوچاو بر آمادگی برای مواجهه با تهدیدات آینده تأکید دارد و خاطرنشان کرد که اسرائیل باید برای دفاع در برابر سلاح‌های لیزری باید آماده باشد.

  3. User

    The genome project will change the face of medicine in Israel and save human lives" Psifas is an ambitious new genome project aiming to create a genetic database of Israel’s citizens, with a budget of NIS 250 million. The collected information already provides information that will make it possible to treat life-threatening diseases in the subjects. The hope is that after accumulating 100,000 samples, the database will help jumpstart the biotech industry. CEO Prof. Gabi Barbash: "Psifas is a great achievement and advantage for Israel, which aspires to become a global hub of biotechnological information." Roni Dori 09:35, 10.11.24 TAGS: Genome Gabi Barbash Roni Dori Interview Ichilov Medical Center

    In a small room on the tenth floor of the Sourasky Building at Ichilov Hospital, one of the most ambitious projects in Israel’s healthcare system is underway: the "Psifas" project, also known as the Israeli Genome Project. Revealed here for the first time, the project aims to create a national clinical genetic database based on samples from 100,000 Israelis. Blood samples collected from volunteers at a station in the hospital lobby are taken to Ziv Itach Abramovitch, the core facility manager at the hospital, where they undergo a series of processes in robotic machines to extract DNA. The DNA is then stored in a freezer at minus 20 degrees before being transferred to another machine, which completes a genetic sequencing process for up to 128 samples at a time within 48 hours, sending the results for further analysis. The project's goal, as announced during its launch at the President’s residence last year, is to "change the world of Israeli medicine." Accordingly, it has been allocated a budget of 250 million shekels. The project is a collaborative effort among various hospitals, with Clalit, Israel's largest HMO, as a major partner. Currently, only Clalit members are eligible to participate in the project and volunteer at designated centers in hospitals across the country. The sequencing center established at Rabin Medical Center is the largest and most advanced in Israel, enabling tens of thousands of genomic sequences per year for Clalit members. Taylor Swift, 33, Takes Off Makeup, Leaves Us With No Words Telehealth Dave Here Are 39 of the Coolest Gifts for This 2024 Trending Gifts Photos That Left Fans In Awe The Noodle Box by TaboolaSponsored Links מנהל הריצוף הגנטי ב בית החולים איכלוב זיו איטח אברמוביץ מאגר פסיפס Ziv Itach Abramovitch, Psifas project, Ichilov Hospital (Photo: Orel Cohen)

    "We joined the leadership of this important national project from the day it was established to provide our members with the most advanced healthcare available—proactive, preventive, and personalized," says Prof. Ran Balicer, Chief Innovation Officer and Deputy Director-General at Clalit Health Services. Prof. Shay Ben Shachar, Head of Precision Medicine at Clalit, adds, "Approximately 4% of Psifas volunteers already receive personalized genomic counseling, allowing them to prevent or reduce the chances of developing serious illnesses with guidance from experts at Israel's leading genomic center." Creating a unique Israeli genetic database is crucial for several reasons. As a diverse, immigrant-based society, Israel encompasses a wide array of genetic characteristics. Each group and origin may have unique genetic traits, with specific studies underway on populations such as those with both parents born in Iraq or Turkey, for example. There is also an economic benefit: data collected from Psifas samples will be available to local research institutions and industry at a subsidized rate. Samples for the project are collected at other hospitals as well, with the aim of making this vast Israeli database accessible to researchers both locally and globally. Prof. Gabi Barbash, CEO of Psifas and former CEO of Ichilov Hospital and the Ministry of Health, explains, “Similar projects exist worldwide, but we believe we have distinct advantages, including our population’s diversity and accessibility to clinical data, as evidenced during the COVID-19 pandemic. Researchers using this database can uncover valuable insights.” “I have no doubt that Donald Trump is anti-Semitic” | CTech CTech Intel brings back free coffee, considering return of company cars | CTech CTech Ad
    These insights include identifying genetic and molecular risk factors for diseases, developing new drugs, examining the effects of existing drugs on various population groups, and personalizing treatments or dosage levels. Additionally, the database supports long-term studies on large populations. "Think of it as academic infrastructure," Barbash describes. "This is a foundational resource that everyone can benefit from, enhancing biotechnological and medical research in Israel and advancing both medicine and industry. Start-ups will have access to this data, eliminating the need to approach individual HMOs and hospitals, as everything is accessible and ready at a subsidized price." Intel closes Israel's Granulate after its 650Mpurchase−andwhosevaluejusttopped650M purchase - and whose value just topped 4 BILLION? 18.3K Video Player is loading.

    Unmute Duration 7:40 / Current Time 0:00

    Advanced Settings

    Fullscreen

    Play

    Rewind 10 Seconds

    Up Next

    logo According to Barbash, "Without the involvement of the Ministry of Health and Moshe Bar Siman Tov during his tenure as CEO of the Ministry eight years ago, and without the support of a budget division within the Treasury that recognized the importance of national biotechnological infrastructure, this project would not have materialized. Today, it is supported by the Planning and Budgeting Committee, the Innovation Authority, and the National Digital Agency." Some insights from the database offer immediate and life-saving potential. One incentive for volunteers is that after DNA sequencing, they will receive the analysis results. If one of the 80 Actionable Genes (AG) associated with heart disease or cancer is detected and validated, they will be notified and can take preventive measures. "This, in a way, is our thank-you to the people who provided both their blood and consent to access their data,” Barbash says. “These are actionable genes where something can be done.” גבי ברבש מנהל ״קונסיליום״ לייעוץ ולווי רפואי כנס רפואה חכמה Prof. Gabi Barbash, CEO, Psifas
    What for example? "There are, for example, genes that indicate heart rhythm disturbances. If detected, a person may be given a pacemaker to prevent sudden issues. Think of the tragic story of a young man who, at 20, suddenly collapses and dies. When you investigate his family history, you may discover a genetic predisposition to arrhythmia." Related articles: Israel Innovation Authority Approves Establishment of Genome Editing Consortium Israel to Establish National Center for Proton Radiation Cancer Therapy Digitization Makes Better Doctors and Nurses, Says Ichilov Hospital CEO Positive response from Israeli participants The project officially launched on January 10, 2023, with the first sample taken from Dr. Avi Gadoth of Ichilov Hospital. Today, nearly two years later, samples have already been collected from close to 50,000 Israelis, with minimal publicity. "The Israeli public has responded positively and is cooperating fully," says Barbash. Currently, only members of Clalit Health Services can participate. However, this limited access underscores the project’s potential. Although the project is only halfway to its sampling goal, it has already prompted initial studies targeting patient groups to investigate potential genetic links to their conditions. Patients from other HMOs can also donate samples if they are invited to participate in these specialized studies. "About 50% of our population has diseases that have not yet been adequately addressed," says Barbash. "Researchers from various hospitals will be able to pose interesting questions about the genetic basis of these diseases and find answers using the database." An example of such research comes from Dr. Ari Raphael, a clinical oncology specialist at Ichilov Hospital, who oversees the "young oncology database." In just a month and a half, this initiative has collected 35 samples. "These are serious and life-threatening diseases, but we often don’t detect the genomic change responsible, nor understand why the tumor developed," he says. "For instance, we’re seeing cancers like digestive system, colon, stomach, breast, and gynecological tumors occurring at younger ages, but we don’t fully understand why. Having a young oncology database is therefore critical." What does it include? "The database includes individuals diagnosed with cancer between the ages of 18 and 40. Beyond genetic information, it encompasses comprehensive clinical data. We use detailed questionnaires that gather information on the specific type and stage of cancer, the organs affected, and the treatments administered. This data has enormous potential for future research, helping us identify common factors among patients. If a genetic change is found, it would be fascinating to investigate if it appears in other family members as well. "Currently, genetic testing isn’t routine for many types of cancer patients, aside from breast and ovarian cancers, which typically include genetic sequencing. For other tumors, genetic testing often isn’t covered, making this Psifas database invaluable by offering high-quality, whole-genome sequencing using Illumina technology to analyze genetic variation and biological function. Genetic changes are assessed against the gene list defined by the American College of Genetics, the most reputable source in this field." "Quick ability to recruit patients" The benefits of this resource for Israel’s biotech industry are substantial. Dr. Liran Shlush, a physician and researcher in the Department of Immunology at the Weizmann Institute, has been working for about three years to develop a simple test to replace bone marrow tests, which are essential for diagnosing many blood cancers. The Psifas project is expected to play a key role in advancing this effort, especially in terms of procedural efficiency. "Each year, about a million bone marrow tests are performed globally, each costing around $3,000. We are developing a simple, affordable blood test that bypasses the need for pathology,” he says. “Psifas is a crucial part of that.” What are the limitations of the current test? "It’s a highly unpleasant procedure that involves smearing and taking a biopsy directly from the bone. It’s also an expensive process requiring multiple professionals—from those who perform the biopsy to those who analyze it. Dr. Amos Tanay, another scientist here at the institute, and I, along with my students, have developed a method that could replace this invasive test with a simple blood draw. We conducted a preliminary study with 100 participants at the Weizmann Institute, which concluded a year ago. To validate our blood test, we need a large group of people who are undergoing a bone marrow test and from whom we can take a blood sample on the same day. Through Psifas, we’ll have access to 600 participants, and they’re helping coordinate the effort across the organization.” How does Psifas assist the project? "Psifas operates in hospitals and has streamlined the process of recruiting patients, quickly obtaining necessary approvals from ethics committees for this type of research. They conduct the study according to clinical research standards, ensuring that it meets the requirements for eventual FDA submission. In Israel, we often struggle to scale a promising idea into a large company. Psifas helps bridge that gap, taking our concept and organizing it into a clinical study that will monitor patients over a three-year period. Psifas has a team that follows all patients and performs comprehensive genomic sequencing for them, providing us with an additional dataset that complements our work." How much time does this save? "On our own, this would have taken us years. We’re now establishing a company, Cliseq, and when we speak to investors, the progress we’ve made with Psifas is a game-changer. Academia often excels at generating ideas, but turning these into clinical research is challenging. Psifas makes this possible." So, Psifas provides an infrastructure that jumpstarts and advances research? "Exactly. Especially in diagnostics, it enables the development of new tests that could transform current practices. Psifas removes significant barriers. Without them, I’d have to approach multiple hospitals, handle ethical approvals, and hire research assistants to recruit patients—tasks that would be nearly impossible to manage. Psifas offers this infrastructure at a relatively low, subsidized cost. We’re trying to run a similar study internationally, and with Psifas, the time was reduced by about 90% and costs were significantly lower. This gives Israel an edge in biotech. Soon, for example, the Weizmann Institute will open a medical school, and we plan to use Psifas as a teaching tool, allowing students to study genetics through Israel’s diverse population database." רן בליצר ראש מערך החדשנות קופ"ח כללית כנס מיקרוסופט בריאות Prof. Ran Balicer, Clalit CIO (Photo: Orel Cohen) "Strict protection of privacy" When asked about his insights from similar projects around the world and why it’s worthwhile for Israel to invest in this initiative, Prof. Barbash responded: “First, there’s the unique diversity of the population in Israel; second, the accessibility to high-quality clinical information that doesn’t exist elsewhere; and third, our ability to reach patients, which we leverage. For example, companies approach us saying, ‘We need you to recruit a specific population that interests us. You already have agreements in place; please recruit these patients because they are crucial to our research.’ There are already two such projects in progress. This collaboration will benefit both the company and Psifas because, ultimately, the data collected on these patients will be available for broader research.” Are there any unique challenges in Israel compared to similar projects elsewhere? “Until now, funding has been the main challenge. If you look at genetic repositories in other countries, like the UK BioBank, the government contributes maybe 15-20% of the budget, while a philanthropic foundation like the Wellcome Trust funds 70-80% of the project. With Psifas, there’s a great achievement and advantage for Israel, which aspires to become a global hub of biotechnological information.” What about privacy protection? “I don’t want to tempt hackers, but we’ve created a highly decentralized and secure system. The clinical data are stored separately and are fully anonymized, with no link to where the volunteers’ identifying information is kept—these are entirely different systems.” Can you explain this in more detail? “There are multiple layers of data encryption. The data stored in Psifas’s system is separated by clinical and demographic categories, and patient names are not identified. We’ve removed identifying details, such as names, ID numbers, and addresses, and adjusted visit dates in the system. So, for example, if someone knew a person visited the ER, they wouldn’t be able to trace them back through this system. "The next step involves a researcher applying for approval from the Helsinki Committee to access the database. We then prepare a dataset that matches the criteria they specified. The researcher receives this data, but only as processed, anonymous information; even the Psifas ID numbers are removed. If the researcher finds something rare and wants to follow up, it’s impossible because the information is fully anonymized. However, we maintain a conversion table that links Psifas IDs to the original patient data, so if actionable genetic findings arise, we can reach out to those individuals directly. But outside of that, the researcher has no way to trace individuals, ensuring complete privacy."

  4. Assistant

    پروژه ژنومی "پسفاس" در اسرائیل قرار است راه‌های جدیدی برای درمان بیماری‌های خطرناک فراهم کند و به ایجاد یک پایگاه داده ژنتیکی از شهروندان اسرائیلی با بودجه 250 میلیون شِکل کمک کند. این پروژه، که ترکیبی از تلاش‌های بیمارستان‌های مختلف و شرکت کلالیت است، به دنبال جمع‌آوری 100,000 نمونه از داوطلبان و ایجاد یک بانک اطلاعاتی ژنتیکی ملی است. پروفسور گابی بارباش، مدیرعامل پسفاس، معتقد است که این پروژه به اسرائیل در رسیدن به اهدافش به عنوان یک مرکز جهانی اطلاعات بیوتکنولوژیکی کمک فراوانی خواهد کرد.

    بر اساس گفته‌های پروفسور رن بالیسر از کلالیت، داوطلبان این پروژه مشاوره ژنتیکی شخصی می‌گیرند که می‌تواند به کاهش احتمال ابتلا به بیماری‌های جدی کمک کند. داده‌های جمع‌آوری شده می‌توانند برای شناسایی عوامل خطر ژنتیکی و مولکولی بیماری‌ها و توسعه داروهای جدید استفاده شوند. بارباش همچنین بر اهمیت محافظت از حریم خصوصی افراد تأکید می‌کند و می‌گوید که اطلاعات ذخیره‌شده کاملاً ناشناس و ایمن هستند. یکی از نقاط قوت این پروژه، تنوع جمعیتی اسرائیل و دسترسی به داده‌های کلینیکی با کیفیت بالا است که می‌تواند به پژوهشگران در کشف بینش‌های ارزشمند کمک کند.